Beta Bionics, Inc. (BBNX)
BBNX moved a median of +0.01% 30 minutes after news, and +0.51% by the close. How BBNX actually reacts to news — the realized, point-in-time move the market made, measured across 541 labeled events over the last three years with zero look-ahead.
BBNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 50% | 514 |
| 30-min | +0.01% | 50% | 514 |
| 60-min | +0.19% | 54% | 514 |
| to close | +0.51% | 57% | 514 |
| Middle 50% of BBNX reactions | -1.34% to +1.53% |
|---|---|
| Median reaction (30-min) | +0.01% |
| Measured reactions | 541 |
Half of all Beta Bionics, Inc. news events land between -1.34% and +1.53% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How BBNX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 10 | +0.01% | 50% | -1.95% |
| Coverage initiations | 45 | -1.21% | 20% | -0.91% |
| Rating reiterations | 36 | 0.00% | 44% | -0.27% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how BBNX ranks against every other measured name →
That’s how BBNX usually reacts — get an email when it moves on news →Email me when BBNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BBNX's baseline. Nothing else.
Recent BBNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026 | Press release | GlobeNewswire | +0.63% | -6.14% | |
| Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX | Press release | PR Newswire | -0.49% | -3.30% | |
| Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX | Press release | PR Newswire | -0.74% | +0.21% | |
| Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); Better Home & Finance Holding Company (NASDAQ: BETR); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your B | Press release | GlobeNewswire | -0.53% | -0.47% | |
| Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026 | Press release | GlobeNewswire | +0.10% | -5.82% | |
| Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365 | Press release | GlobeNewswire | +0.81% | +2.84% | |
| Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026 | Press release | GlobeNewswire | -0.07% | +0.48% | |
| Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock | Press release | GlobeNewswire | +1.36% | +2.77% | |
| Form 8-K Beta Bionics, Inc. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | -1.81% | -4.59% | |
| Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants | Press release | GlobeNewswire | +7.82% | +18.80% | |
| Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock | Press release | GlobeNewswire | +7.82% | +18.80% | |
| Form 8-K Beta Bionics, Inc. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | +7.82% | +18.80% | |
| Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm | Press release | GlobeNewswire | +8.05% | +7.80% | |
| Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX | Press release | PR Newswire | -0.96% | +0.78% | |
| Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX | Press release | Business Wire | -0.96% | +0.78% | |
| Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | Press release | GlobeNewswire | -1.03% | -10.64% | |
| Form 10-Q Beta Bionics, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.03% | -10.64% | |
| Form 8-K Beta Bionics, Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | -1.03% | -10.64% | |
| Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 | Press release | GlobeNewswire | +0.75% | +4.96% | |
| Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website | Press release | GlobeNewswire | +0.36% | +1.99% | |
| Form 8-K Beta Bionics, Inc. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +0.52% | |
| Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development | Press release | GlobeNewswire | -0.40% | +5.44% | |
| Form 8-K Beta Bionics, Inc. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -0.40% | +5.44% | |
| Beta Bionics to Present at the Bank of America Securities Health Care Conference | Press release | GlobeNewswire | -0.09% | -5.35% | |
| Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | Press release | GlobeNewswire | -9.72% | -5.86% | |
| Form 10-Q Beta Bionics, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -9.72% | -5.86% | |
| Form 8-K Beta Bionics, Inc. For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -9.72% | -5.86% | |
| Form ARS Beta Bionics, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +2.31% | +19.71% | |
| Form DEF 14A Beta Bionics, Inc. For: May 21 | SEC filing · Form DEF | SEC EDGAR | +2.31% | +19.71% | |
| Form DEFA14A Beta Bionics, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +2.31% | +19.71% | |
| Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care | Press release | GlobeNewswire | +0.15% | +0.91% | |
| Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026 | Press release | GlobeNewswire | +0.15% | +0.91% | |
| Form 10-K Beta Bionics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.57% | -2.53% | |
| Form S-3ASR Beta Bionics, Inc. | SEC filing · Form S-3ASR | SEC EDGAR | -0.57% | -2.53% | |
| Form S-8 Beta Bionics, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.57% | -2.53% | |
| Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference | Press release | GlobeNewswire | -4.16% | +0.00% | |
| Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | Press release | GlobeNewswire | -3.44% | +8.79% | |
| Form 8-K Beta Bionics, Inc. For: Feb 17 | SEC filing · Form 8-K | SEC EDGAR | -3.44% | +8.79% | |
| Form 8-K Beta Bionics, Inc. For: Jan 29 | SEC filing · Form 8-K | SEC EDGAR | -0.84% | -0.07% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.30% | +0.51% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.31% | -5.04% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Beta Bionics, Inc. (BBNX) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.50% | -2.58% | |
| Beta Bionics, Inc. (BBNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.97% | -5.89% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Beta Bionics, Inc. (BBNX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -1.45% | +2.73% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.69% | +2.58% | |
| Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 | Press release | GlobeNewswire | -1.24% | +4.46% | |
| Beta Bionics, Inc. (BBNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.29% | +4.96% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Beta Bionics, Inc. (BBNX) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.44% | +2.91% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Beta Bionics, Inc. (BBNX) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.27% | +2.52% | |
| Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | Press release | GlobeNewswire | -1.67% | -11.47% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BBNX section they belong to.
Where else BBNX is measured.
BBNX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Beta Bionics, Inc.'s median reaction calculated?
Every labeled BBNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 541 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of BBNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BBNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.